Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.
Tabellini, Giovanna; Vairo, Donatella; Scomodon, Omar; Tamassia, Nicola; Ferraro, Rosalba Monica; Patrizi, Ornella; Gasperini, Sara; Soresina, Annarosa; Giardino, Giuliana; Pignata, Claudio; Lougaris, Vassilios; Plebani, Alessandro; Dotta, Laura; Cassatella, Marco A; Parolini, Silvia; Badolato, Raffaele.
J Allergy Clin Immunol
; 140(2): 553-564.e4, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28069426
Epigenetic control of innate and adaptive immune memory.
Chronic mucocutaneous candidiasis associated with an SH2 domain gain-of-function mutation that enhances STAT1 phosphorylation.
Molecular mechanism and structural basis of gain-of-function of STAT1 caused by pathogenic R274Q mutation.
Chronic mucocutaneous candidiasis due to gain-of-function mutation in STAT1.
Autosomal dominant cases of chronic mucocutaneous candidiasis segregates with mutations of signal transducer and activator of transcription 1, but not of Toll-like receptor 3.
HDAC inhibitors modulate innate immune responses to micro-organisms relevant to chronic mucocutaneous candidiasis.
Modulation of antitumour immune responses by intratumoural Stat1 expression.
Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.
New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe.
Both NK cell-intrinsic and -extrinsic STAT1 signaling are required for NK cell response against vaccinia virus.